Birdwatch Note
2024-04-30 07:46:04 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Riporta una opinione e non dati verificati "Allo stato attuale delle conoscenze e dei report, dopo la vaccinazione mRNA contro il COVID-19 si possono verificare molto raramente e, comunemente, si manifestano con forme cliniche caratterizzate da un’evoluzione favorevole." https://www.corriere.it/salute/cardiologia/23_novembre_15/miocarditi-pericarditi-vaccino-covid-cosa-successo-davvero-a3b98c60-7e1f-11ee-b4e1-753cfb3840d0.shtml https://www.giornaledicardiologia.it/archivio/3689/articoli/36747/
Written by A2B04E3718812E17A2000BB348F28C9BF95094794270D27EF723D72F0043C0FC
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1785049525524054018
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1785214019629994003
- noteId - 1785214019629994003
- participantId -
- noteAuthorParticipantId - A2B04E3718812E17A2000BB348F28C9BF95094794270D27EF723D72F0043C0FC
- createdAtMillis - 1714463164609
- tweetId - 1785049525524054018
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Riporta una opinione e non dati verificati "Allo stato attuale delle conoscenze e dei report, dopo la vaccinazione mRNA contro il COVID-19 si possono verificare molto raramente e, comunemente, si manifestano con forme cliniche caratterizzate da un’evoluzione favorevole." https://www.corriere.it/salute/cardiologia/23_novembre_15/miocarditi-pericarditi-vaccino-covid-cosa-successo-davvero-a3b98c60-7e1f-11ee-b4e1-753cfb3840d0.shtml https://www.giornaledicardiologia.it/archivio/3689/articoli/36747/
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2024-04-30 07:46:04 UTC (1714463164609) |
2024-04-30 10:26:47 UTC (1714472807396) |
CURRENTLY_RATED_HELPFUL | 2024-05-01 12:35:12 UTC (1714566912495) |
CURRENTLY_RATED_HELPFUL | 2024-04-30 10:26:47 UTC (1714472807396) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
| rated at | rated by | |
| 2024-04-30 19:12:09 -0500 | Rating Details | |
| 2024-04-30 17:09:48 -0500 | Rating Details | |
| 2024-04-30 12:27:14 -0500 | Rating Details | |
| 2024-04-30 06:56:25 -0500 | Rating Details | |
| 2024-04-30 06:37:20 -0500 | Rating Details | |
| 2024-04-30 06:36:12 -0500 | Rating Details | |
| 2024-04-30 06:00:34 -0500 | Rating Details | |
| 2024-04-30 05:59:33 -0500 | Rating Details | |
| 2024-04-30 04:39:11 -0500 | Rating Details | |
| 2024-04-30 03:41:08 -0500 | Rating Details | |
| 2024-04-30 03:29:49 -0500 | Rating Details | |
| 2024-04-30 03:21:23 -0500 | Rating Details | |
| 2024-04-30 03:13:07 -0500 | Rating Details | |
| 2024-04-30 03:00:23 -0500 | Rating Details | |
| 2024-04-30 02:58:54 -0500 | Rating Details | |
| 2024-04-30 02:49:59 -0500 | Rating Details | |
| 2024-05-01 02:24:52 -0500 | Rating Details | |
| 2024-05-01 00:20:02 -0500 | Rating Details | |
| 2024-05-01 03:03:16 -0500 | Rating Details | |
| 2024-05-01 01:52:33 -0500 | Rating Details | |
| 2024-04-30 17:04:15 -0500 | Rating Details | |
| 2024-04-30 16:35:56 -0500 | Rating Details | |
| 2024-04-30 11:47:30 -0500 | Rating Details | |
| 2024-04-30 11:27:05 -0500 | Rating Details | |
| 2024-04-30 10:08:01 -0500 | Rating Details | |
| 2024-04-30 09:40:14 -0500 | Rating Details | |
| 2024-04-30 08:30:23 -0500 | Rating Details | |
| 2024-04-30 08:16:55 -0500 | Rating Details | |
| 2024-04-30 08:11:33 -0500 | Rating Details | |
| 2024-04-30 07:36:22 -0500 | Rating Details | |
| 2024-04-30 06:16:07 -0500 | Rating Details | |
| 2024-04-30 06:14:41 -0500 | Rating Details | |
| 2024-04-30 05:41:10 -0500 | Rating Details | |
| 2024-04-30 04:42:20 -0500 | Rating Details | |
| 2024-04-30 04:36:39 -0500 | Rating Details | |
| 2024-04-30 03:42:53 -0500 | Rating Details | |
| 2024-04-30 02:59:48 -0500 | Rating Details | |
| 2024-05-01 01:53:31 -0500 | Rating Details | |
| 2024-04-30 17:37:12 -0500 | Rating Details | |
| 2024-04-30 14:29:50 -0500 | Rating Details | |
| 2024-04-30 13:39:41 -0500 | Rating Details | |
| 2024-04-30 13:15:55 -0500 | Rating Details | |
| 2024-04-30 12:32:53 -0500 | Rating Details | |
| 2024-04-30 10:39:10 -0500 | Rating Details | |
| 2024-04-30 09:30:51 -0500 | Rating Details | |
| 2024-04-30 09:18:36 -0500 | Rating Details | |
| 2024-04-30 07:54:57 -0500 | Rating Details | |
| 2024-04-30 07:22:49 -0500 | Rating Details | |
| 2024-04-30 06:25:55 -0500 | Rating Details | |
| 2024-04-30 06:20:25 -0500 | Rating Details | |
| 2024-04-30 05:28:48 -0500 | Rating Details | |
| 2024-04-30 04:48:54 -0500 | Rating Details | |
| 2024-04-30 03:32:23 -0500 | Rating Details | |
| 2024-04-30 03:24:38 -0500 | Rating Details | |
| 2024-04-30 03:22:05 -0500 | Rating Details | |
| 2024-04-30 03:08:25 -0500 | Rating Details | |
| 2024-04-30 02:57:55 -0500 | Rating Details | |
| 2024-04-30 02:56:27 -0500 | Rating Details | |
| 2024-05-02 04:55:11 -0500 | Rating Details | |
| 2024-05-03 09:46:14 -0500 | Rating Details | |
| 2024-04-30 11:18:37 -0500 | Rating Details | |
| 2024-04-30 11:03:34 -0500 | Rating Details | |
| 2024-04-30 10:02:45 -0500 | Rating Details | |
| 2024-04-30 08:32:09 -0500 | Rating Details | |
| 2024-04-30 06:16:24 -0500 | Rating Details | |
| 2024-04-30 06:08:51 -0500 | Rating Details | |
| 2024-04-30 05:46:19 -0500 | Rating Details | |
| 2024-04-30 05:45:47 -0500 | Rating Details | |
| 2024-04-30 05:45:01 -0500 | Rating Details | |
| 2024-04-30 05:39:09 -0500 | Rating Details | |
| 2024-04-30 05:11:38 -0500 | Rating Details | |
| 2024-04-30 04:23:39 -0500 | Rating Details | |
| 2024-04-30 03:45:34 -0500 | Rating Details | |
| 2024-04-30 03:21:24 -0500 | Rating Details | |
| 2024-04-30 03:17:54 -0500 | Rating Details | |
| 2024-04-30 03:00:36 -0500 | Rating Details | |
| 2024-04-30 02:57:46 -0500 | Rating Details | |
| 2024-04-30 02:57:25 -0500 | Rating Details | |
| 2024-04-30 02:49:49 -0500 | Rating Details | |
| 2024-04-30 12:37:12 -0500 | Rating Details | |
| 2024-04-30 09:28:25 -0500 | Rating Details | |
| 2024-04-30 14:27:47 -0500 | Rating Details | |
| 2024-04-30 06:24:04 -0500 | Rating Details | |
| 2024-04-30 03:16:11 -0500 | Rating Details |